Signet Private Wealth »

United Therapeutics Corporation shares owned by Signet Private Wealth

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Signet Private Wealth from 13F filings

Historical chart of Signet Private Wealth investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Signet Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Signet Private Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $245k 413 592.98

More positions owned by Signet Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Spdr Series Trust State Street Spd (BIL)
Global X Fds S&p 500 Catholic (CATH)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Msci Acwi Ex Us (ACWX)

View all positions for Signet Private Wealth

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation